Metformin's Enigma: Bridging Gaps in Research on Potential Benefits & Associated Risks - A Critical Plea for Comprehensive Investigation [Response to Letter].

Authors :: Dutta S
Shah RB
Singhal S
Dutta SB
Bansal S
Sinha S
Haque M
Source :: Drug design, development and therapy [Drug Des Devel Ther] 2024 Sep 07; Vol. 18, pp. 4029-4031. Date of Electronic Publication: 2024 Sep 07 (Print Publication: 2024).
Publication Year :: 2024
Abstract: Competing Interests: The authors report no conflicts of interest in this communication.

Subjects :: Humans
Diabetes Mellitus, Type 2 drug therapy
Metformin pharmacology
Hypoglycemic Agents pharmacology

Full Text Access

Tools